Indicated for: hypertension
Route of administration: oral
Substance: atropine sulfate + ergoton + propranolol + amobarbital sodium (mydriatic + antihypertensive + beta blocker + sedative-hypnotic)
ATC: C07NAN1 (Cardiovascular system | )
This combination of atropine sulfate, ergoton, propranolol, and sodium amobarbital is used for the treatment of severe migraines and other vascular disorders. Atropine sulfate reduces muscle spasms, ergoton improves vascular tone, propranolol lowers heart rate, and amobarbital has a sedative effect.
The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the prescribed dosage and avoid alcohol consumption during treatment.
Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include drowsiness, dizziness, nausea, and dry mouth. In rare cases, severe reactions such as respiratory depression or allergic reactions may occur. Patients should be informed of these risks before starting treatment.